Stay updated on Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.

Latest updates to the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedAdded a comprehensive list of trial locations across multiple states and countries, and removed several locations from the list.SummaryDifference2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe study locations list has been expanded to 174 sites across the United States and internationally, including UC San Diego, Yale-New Haven, Massachusetts General Hospital, OHSU, and Ophthalmic Consultants of Boston. The total number of locations shown is now 174.SummaryDifference0.8%

- Check35 days agoChange DetectedPubMed publications note text was updated to state that publications are automatically filled in from PubMed, a public database of scientific and medical articles, with a version update to v3.3.2.SummaryDifference0.0%

- Check43 days agoChange DetectedRemoved the general government funding operating-status notice from the page; the study details and inclusion criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedThere are no significant changes between the two screenshots. The study details and listed locations appear unchanged.SummaryDifference0.2%

- Check78 days agoChange DetectedAdded a new Publications section with a PubMed citation and expanded list of study locations; removed several earlier locations and some institutions. Overall, core content and proper nouns expanded while some location details were simplified.SummaryDifference7%

Stay in the know with updates to Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.